Search

everythinglearnresearchcommunity

for

Search:↓

Women with mild acne are more likely to have polycystic ovary syndrome (PCOS) than those without acne.

Effective hirsutism management requires identifying the cause, combining new and traditional treatments, and setting realistic expectations for patients.

Some breast cancer patients on hormonal therapy may develop male or female pattern hair loss, which can sometimes be improved with topical treatments.

The conference highlighted new dermatological treatments and emphasized early intervention and addressing conditions lacking evidence-based treatments.

Early treatment and weight management are important for teenagers with PCOS to reduce symptoms and long-term health risks.

Hirsutism is when women have too much hair growth, often due to a bit more androgen hormones and sensitive skin.

Hirsutism in teen girls is common, usually harmless, but can sometimes signal serious issues and is treatable.

The guideline provides healthcare professionals in South Africa with instructions for comprehensive, multidisciplinary gender-affirming care, including HIV prevention and treatment for transgender and gender diverse individuals.

The conclusion is that proper diagnosis and long-term treatment, including medication, hair removal, and lifestyle changes, are important for improving hirsutism, especially in PCOS patients.

Low-dose oral minoxidil and spironolactone combo effectively reduces hair loss and improves hair density in women.

Both treatment combinations improved hair growth similarly and were safe.

Oral estradiol works for many transgender women but needs personalized dosing and monitoring.

Combination therapy with oral contraceptives and spironolactone improves hair growth, menstrual issues, and acne in women with PCOS.

Hormone therapy with estradiol and spironolactone can regrow scalp hair in transgender women by lowering testosterone to female levels.

The document concludes that treatments for hair loss in transgender and gender-diverse individuals include topical solutions, oral medications, laser therapy, and hair restoration procedures, with progress assessed after 6-12 months.

Spironolactone effectively makes hair shafts thinner in women with excessive hair growth.

Dermatologists recommend oral dutasteride for male hair loss, low-dose oral minoxidil for female hair loss, and a multidisciplinary approach for young patients, with caution during pregnancy.

Hormonal treatment is effective for women with acne not helped by usual treatments, especially if they have hormonal imbalances.

Excessive hair growth in women can be harmless or signal serious health issues, and treatment often includes medication and hair removal, with noticeable results after 3-6 months.

The document concludes that treating androgen excess needs patience, managing expectations is important, and many drugs used are not officially approved, suggesting cosmetic options for mild cases.

Birth control pills and anti-androgen medications help manage hair growth, acne, and hair loss in women with PCOS.

Minoxidil is an effective and safe treatment for common hair loss when applied to the skin, but more research is needed for optimal use.

Non-classic congenital adrenal hyperplasia (NCCAH) can mimic PCOS and requires genetic testing for proper diagnosis and treatment.

Diagnosing and treating PCOS is complex due to differing criteria and requires a team approach.

Hormonal treatments can help with hair loss, acne, and excess hair growth, but it takes 3-6 months to see results and patients should know the possible side effects.

Treatment improved symptoms in a woman with HAIR-AN syndrome.

Topical minoxidil is the best-supported treatment for female hair loss, but personalized plans are needed.

Topical minoxidil is the primary treatment for female pattern hair loss in India.

Medical practitioners need to understand basic statistics to properly evaluate clinical trials and avoid unethical designs.